1. Home
  2. VRAX vs NURO Comparison

VRAX vs NURO Comparison

Compare VRAX & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • NURO
  • Stock Information
  • Founded
  • VRAX 2013
  • NURO 1996
  • Country
  • VRAX United Kingdom
  • NURO United States
  • Employees
  • VRAX N/A
  • NURO N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • NURO Medical/Dental Instruments
  • Sector
  • VRAX Health Care
  • NURO Health Care
  • Exchange
  • VRAX Nasdaq
  • NURO Nasdaq
  • Market Cap
  • VRAX 7.3M
  • NURO 8.2M
  • IPO Year
  • VRAX 2022
  • NURO N/A
  • Fundamental
  • Price
  • VRAX $1.66
  • NURO $4.38
  • Analyst Decision
  • VRAX
  • NURO
  • Analyst Count
  • VRAX 0
  • NURO 0
  • Target Price
  • VRAX N/A
  • NURO N/A
  • AVG Volume (30 Days)
  • VRAX 256.7K
  • NURO 21.7K
  • Earning Date
  • VRAX 02-05-2025
  • NURO 02-20-2025
  • Dividend Yield
  • VRAX N/A
  • NURO N/A
  • EPS Growth
  • VRAX N/A
  • NURO N/A
  • EPS
  • VRAX N/A
  • NURO N/A
  • Revenue
  • VRAX $84,872.00
  • NURO $3,767,764.00
  • Revenue This Year
  • VRAX $5,169.18
  • NURO N/A
  • Revenue Next Year
  • VRAX $66.97
  • NURO N/A
  • P/E Ratio
  • VRAX N/A
  • NURO N/A
  • Revenue Growth
  • VRAX 7.03
  • NURO N/A
  • 52 Week Low
  • VRAX $0.60
  • NURO $2.66
  • 52 Week High
  • VRAX $9.00
  • NURO $4.73
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 42.25
  • NURO 67.97
  • Support Level
  • VRAX $1.56
  • NURO $4.16
  • Resistance Level
  • VRAX $1.86
  • NURO $4.40
  • Average True Range (ATR)
  • VRAX 0.19
  • NURO 0.09
  • MACD
  • VRAX -0.04
  • NURO 0.03
  • Stochastic Oscillator
  • VRAX 26.31
  • NURO 95.24

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

Share on Social Networks: